Harbor BioSciences, Inc. (HRBR) Preclinical Study of Apoptone(R) in Breast Cancer Published in the International Journal of Breast Cancer
2/28/2011 9:57:56 AM
More...
|
Initial Studies Show Harbor BioSciences, Inc. (HRBR)' Triolex(R) for Parkinson's Disease Crosses the Blood-Brain Barrier in Mice
2/22/2011 9:43:35 AM
More...
|
Harbor BioSciences, Inc. (HRBR) Wraps Up Phase I/IIa Prostate Cancer Study
2/7/2011 10:04:02 AM
More...
|
Harbor BioSciences, Inc. (HRBR) Discovery of New Anti-Inflammatory Steroids Published in Peer Reviewed Scientific Journal
2/1/2011 10:21:39 AM
More...
|
Harbor BioSciences, Inc. (HRBR) Signs Pharmaceutical Development Agreements With China State Institute of Pharmaceutical Industry (CIPI)
1/18/2011 11:31:24 AM
More...
|
Harbor BioSciences, Inc. (HRBR) Receives Patent for Triolex(R) and Other Compounds
9/22/2010 11:07:39 AM
More...
|
Harbor BioSciences, Inc. (HRBR) Receives NASDAQ Notice of Delisting
9/20/2010 11:05:48 AM
More...
|
Harbor BioSciences, Inc. (HRBR) Apoptone(R) for Prostate Cancer Shows a Partial Overall Response
9/15/2010 11:33:29 AM
More...
|
Harbor BioSciences, Inc. (HRBR) Announces Closing of $2.06 Million Equity Financing
6/11/2010 10:18:03 AM
More...
|
Harbor BioSciences, Inc. (HRBR) Apoptone(R) for Prostate Cancer Shows Activity at All Doses Tested
6/7/2010 2:02:59 PM
More...
|
|